image

The best stocks to buy since 1993

Latest issue now available

Kape - +68% upgrade to eps forecasts

April 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KAPE
  • Price:
  • 288p
The shares went into orbit after Kape acquired Israel-based Webselenese for US$149.1m (US$116.6m cash plus 12.1m shares) from its two founders who end up with a 5.4% holding. A few days later it announced its results with sales +85% to US$122.2m, EBITDA +168% to US$39m and eps +107% to 13.5 cents. EBITDA margins rose almost 10% to 31.9% as benefits of scale from the earlier PIA acquisition kicked in and post acquisition synergies were higher than expected. In the light of the deal, ShoreCap upgrades eps by 68% to 25.5 cents, with next year lifted 31% to 33.3 cents. CEO Ido Erlichman says Kape has been working with Webselenese since 2017 following the acquisition of Cyberghost. Webselenese owns a number of privacy and security ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe